Last10K.com

Tiziana Life Sciences Plc (TLSA) SEC Filing 6-K Foreign Issuer report for the period ending Wednesday, May 6, 2020

Tiziana Life Sciences Plc

CIK: 1723069 Ticker: TLSA

View differences made from one to another to evaluate Tiziana Life Sciences Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Tiziana Life Sciences Plc.

Continue

Assess how Tiziana Life Sciences Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Tiziana Life Sciences Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Tiziana Life Sciences Plc provided additional information to their SEC Filing as exhibits

Ticker: TLSA
CIK: 1723069
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001213900-20-011106
Submitted to the SEC: Wed May 06 2020 7:21:56 AM EST
Accepted by the SEC: Wed May 06 2020
Period: Wednesday, May 6, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/tlsa/0001213900-20-011106.htm